期刊文献+

血细胞分离机行血浆置换在危重病人中的应用研究 被引量:5

Plasma exchange by use of corpuscle separator in intense care patients ICU
下载PDF
导出
摘要 目的 观察血细胞分离机COBESPECTRA血液分离系统在危重病人中行血浆置换的有效性和安全性。方法 利用COBESPECTRA血液分离系统为27例重症病人共行59次血浆置换,置换液为新鲜冰冻血浆,抗凝剂为3%枸橼酸钠溶液(ACD—A),观察治疗过程的生命体征变化,治疗前后的血常规、电解质、凝血指标变化,记录治疗时间、置换量、血流速度、抗凝剂用量等参数。结果 治疗过程中患者生命体征平稳,临床症状改善;治疗时间180±30min,置换量3.2±0.9L,血流速度40~80ml/min,ACD—A用量800±50ml。治疗后凝血指标改善明显,但出现血钠升高,血小板下降的情况.结论 应用血液分离系统在危重病人中行血浆置换有效,安全性高,但仍需注意并发症的发生。 Objective To investigate the effectiveness and safety of plasma exchange in intense care patients by use of blood corpuscle separator ( COBE SPECTRA system). Methods 59 times of plasma exchange were performed in 27 patients in intense care unit by use of COBE SPEC- TRA system. Frozen plasma was used as substitution fluid, 3% sodium citrate was used as anticoagulant. Changes in vital signs during treatment, and blood routine tests, blood electrolytes, blood coagulation index were observed before and after treatment ; Therapeutic time, substitution quantity, blood flow rate, anticoagulant used were recorded. Results Stable vital signs were maintained in all patients during treatment, clinic symptoms improved. Treatment lasted 180±30 min, substitution quantity was 3.2 ±0.9 L, blood flow rate 40 -80 mL/min, ACD -A used 800 ±50 ml. After treatment, coagulation index improved significantly, but there was a rise in blood sodium concentration and a fall in blood platelet count. Conclusion Plasma exchange in intense care patients by use of COBE SPECTRA system is effective and safe, but careful attention must be paid to side effects.
出处 《临床和实验医学杂志》 2007年第6期53-54,共2页 Journal of Clinical and Experimental Medicine
关键词 血细胞分离机 血液分离系统 血浆置换 危重病人 Blood corpuscle separator COBE SPECTRA system Plasma exchang Intense care patients
  • 相关文献

参考文献2

二级参考文献12

  • 1Nakaji S, Yamamoto T. Membranes for therapeutic apheresis. Ther Apher,2002,6:267.
  • 2Yokoyama H, Wads T, Furuichi K. Immunomodulation effects and clinical evidence of apheresis in renal diseases. Ther Apher Dial, 2003,7 : 497.
  • 3Yeh JH, Chen WH, Chiu HC. Hemodynamic effects of the different vascular accesses used for double-filtration plasmapheresis.J Clin Apheresis,2001,16:125.
  • 4Kaplan AA. Therapeutic apheresis for renal disorders. Ther Apher, 1999,3:25.
  • 5Russo GE, Bonello M, Bauco B, et al. Nephrotic syndrome and plasmapheresis. Int J Artif Organs, 2000 Feb, 23: 111.
  • 6Tanabe K, Tokumoto T, Ishida H, et al. ABO-incompatible renal transplantation at Tokyo Women's Medical University. Clin Transpl, 2003,175.
  • 7Otsubo S, Tanabe K, Shinmura H, et al. Effect of post-transplant doubl filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients. Ther Apher Dial,2004,8 :299.
  • 8Siami GA, Siami FS. Membrane plasmapheresis in the United States: a review over the last 20 years. Ther Apher, 2001,5:315.
  • 9Yeh JH, Chen WH, Chiu HC. Complications of double-filtration plasrnapheresis. Transfusion, 2004,44:1621.
  • 10Lin SM, Yeh JH, Lee CC,et al. Clearance of fibfinogen and von Willebrand factor in serial double-filtration plasmaphereais J Clin Apheresis, 2003,18: 67.

共引文献27

同被引文献30

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部